Company profile for Alpha Cancer Technologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alpha Cancer Technologies Inc. (ACT) is a private clinical stage biotechnology company with products under development in immunomodulation and immuno-oncology. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP). ACT has exclusive worldwide rights to AFP with over $100 million spent on the development of the in-licensed technology. Clinical studies of AFP have demonstrated safety in over...
Alpha Cancer Technologies Inc. (ACT) is a private clinical stage biotechnology company with products under development in immunomodulation and immuno-oncology. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP). ACT has exclusive worldwide rights to AFP with over $100 million spent on the development of the in-licensed technology. Clinical studies of AFP have demonstrated safety in over 300 patients and established a robust Drug Master file with the FDA including manufacturing, toxicology, and human safety.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
MaRs Centre - South Tower 200-101 College St. Toronto, Ontario, M5G 1L7
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty